Search results
Shah Capital ends campaign against Novavax board after Sanofi deal
Reuters· 4 days agoUnder a deal signed on May 10, the French drugmaker will take a 4.9% stake in Novavax for $70...
Could Novavax Become the Next Moderna?
The Motley Fool via AOL· 7 days agoIn contrast, Moderna has more than 40 candidates in the pipeline, and as mentioned above, expects to launch several products within the next few years....
Better Buy: Inovio Pharmaceuticals vs. Novavax
Motley Fool via Yahoo Finance· 2 days agoThere are much more attractive stocks in the biotech industry. Should you invest $1,000 in Novavax right now? Before you buy stock in Novavax< ...
Novavax, Inc. (NASDAQ: NVAX) Today’s Hot Stock – Stocks Register
Stocks Register· 3 days agoLooking at the stock we see that its previous close was $13.01 . In terms of its 52-week price range, NVAX has a high of $15.00 and a low of $3.53. The company’s ...
The Zacks Analyst Blog Highlights Novavax, Sanofi, Fulcrum Therapeutics, Moderna and Bristol Myers
Zacks via Yahoo Finance· 7 days agoStocks recently featured in the blog include: Novavax, Inc. NVAX, Sanofi SNY, Fulcrum Therapeutics,...
This Stock Just More Than Doubled in 1 Day: Is It a Buy? | The Motley Fool
The Motley Fool· 5 days agoThe biotech has come a long way since its not-so-successful attempt at dominating the coronavirus...
Could Novavax Become the Next Moderna? | The Motley Fool
The Motley Fool· 7 days agoInvestors were betting on the companies...vaccine market along with big pharma rival Pfizer, and...
Better Buy: Inovio Pharmaceuticals vs. Novavax | The Motley Fool
The Motley Fool· 2 days agoThe COVID-19 vaccine was worth tens of billions of dollars, but most of it went into the hands of...
Heard on the Street: Moderna Got a Boost From Bird Flu, but Don’t Count Your Chicks
The Wall Street Journal· 14 hours agoModerna, BioNTech, CureVac and Novavax have added billions of dollars in combined market...
Bird Flu Cases Spur Retail Trader Rush Into Vaccine Stocks
Bloomberg via Yahoo Finance· 1 day ago(Bloomberg) -- Mounting cases of bird flu in humans is luring the day trading crowd to snap up stock...